{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:44:22Z","timestamp":1793411062275,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s13555-017-0194-1","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T07:03:23Z","timestamp":1500447803000},"page":"305-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":306,"title":["Melasma: an Up-to-Date Comprehensive Review"],"prefix":"10.1007","volume":"7","author":[{"given":"Oluwatobi A.","family":"Ogbechie-Godec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"issue":"6","key":"194_CR1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0190-9622(81)70071-9","volume":"4","author":"NP Sanchez","year":"1981","unstructured":"Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4(6):698\u2013710 (PubMed PMID: 6787100).","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"194_CR2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1468-3083.2010.03592.x","volume":"24","author":"C Guinot","year":"2010","unstructured":"Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. 2010;24(9):1060\u20139 (PubMed PMID: 20202051).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"194_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1468-3083.2011.04430.x","volume":"27","author":"A Tamega Ade","year":"2013","unstructured":"Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151\u20136 (PubMed PMID: 22212073).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"194_CR4","first-page":"231","volume":"19","author":"R Mandry Pagan","year":"2000","unstructured":"Mandry Pagan R, Sanchez JL. Mandibular melasma. P R Health Sci J. 2000;19(3):231\u20134 (PubMed PMID: 11076368).","journal-title":"P R Health Sci J"},{"issue":"9","key":"194_CR5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2012.04655.x","volume":"27","author":"CG Ritter","year":"2013","unstructured":"Ritter CG, Fiss DV, Borges da Costa JA, de Carvalho RR, Bauermann G, Cestari TF. Extra-facial melasma: clinical, histopathological, and immunohistochemical case\u2013control study. J Eur Acad Dermatol Venereol. 2013;27(9):1088\u201394 (PubMed PMID: 22827850).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"194_CR6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-4632.2012.05748.x","volume":"53","author":"D Hexsel","year":"2014","unstructured":"Hexsel D, Lacerda DA, Cavalcante AS, Machado Filho CA, Kalil CL, Ayres EL, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014;53(4):440\u20134 (PubMed PMID: 23967822).","journal-title":"Int J Dermatol"},{"issue":"4","key":"194_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-4632.2011.05305.x","volume":"52","author":"SN Mishra","year":"2013","unstructured":"Mishra SN, Dhurat RS, Deshpande DJ, Nayak CS. Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis. Int J Dermatol. 2013;52(4):413\u20137 (PubMed PMID: 22348652).","journal-title":"Int J Dermatol"},{"issue":"4","key":"194_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/0019-5154.84722","volume":"56","author":"A Achar","year":"2011","unstructured":"Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011;56(4):380\u20132 (PubMed PMID: 21965843. Pubmed Central PMCID: 3178998).","journal-title":"Indian J Dermatol"},{"issue":"2","key":"194_CR9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.dad.0000154419.18653.2e","volume":"27","author":"PE Grimes","year":"2005","unstructured":"Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol. 2005;27(2):96\u2013101 (PubMed PMID: 15798432).","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"194_CR10","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1111\/j.1600-0625.2009.01057.x","volume":"19","author":"HY Kang","year":"2010","unstructured":"Kang HY, Bahadoran P, Suzuki I, Zugaj D, Khemis A, Passeron T, et al. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol. 2010;19(8):e228\u201333 (PubMed PMID: 20497220).","journal-title":"Exp Dermatol"},{"issue":"10","key":"194_CR11","first-page":"218","volume":"2","author":"N Bagherani","year":"2015","unstructured":"Bagherani N, Gianfaldoni S, Smoller BR. An overview on melasma. J Pigment Disord. 2015;2(10):218.","journal-title":"J Pigment Disord."},{"issue":"3","key":"194_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4632.2004.02470.x","volume":"45","author":"A Moin","year":"2006","unstructured":"Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol. 2006;45(3):285\u20138 (PubMed PMID: 16533230).","journal-title":"Int J Dermatol"},{"issue":"3","key":"194_CR13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/0378-6323.79741","volume":"77","author":"SP Rathore","year":"2011","unstructured":"Rathore SP, Gupta S, Gupta V. Pattern and prevalence of physiological cutaneous changes in pregnancy: a study of 2000 antenatal women. Indian J Dermatol Venereol Leprol. 2011;77(3):402 (PubMed PMID: 21508591).","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"194_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.143.3.424","volume":"143","author":"KD Werlinger","year":"2007","unstructured":"Werlinger KD, Guevara IL, Gonzalez CM, Rincon ET, Caetano R, Haley RW, et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):424\u20135 (PubMed PMID: 17372115).","journal-title":"Arch Dermatol"},{"issue":"4","key":"194_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0733-8635(03)00075-5","volume":"21","author":"SC Taylor","year":"2003","unstructured":"Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin. 2003;21(4):601\u20137 (PubMed PMID: 14717401).","journal-title":"Dermatol Clin"},{"issue":"4","key":"194_CR16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8635(03)00087-1","volume":"21","author":"MR Sanchez","year":"2003","unstructured":"Sanchez MR. Cutaneous diseases in Latinos. Dermatol Clin. 2003;21(4):689\u201397 (PubMed PMID: 14717409).","journal-title":"Dermatol Clin"},{"issue":"6","key":"194_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5144\/0256-4947.1998.558","volume":"18","author":"A Parthasaradhi","year":"1998","unstructured":"Parthasaradhi A, Al Gufai AF. The pattern of skin diseases in Hail Region, Saudi Arabia. Ann Saudi Med. 1998;18(6):558\u201361 (PubMed PMID: 17344753).","journal-title":"Ann Saudi Med."},{"issue":"6","key":"194_CR18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaad.2007.01.031","volume":"56","author":"D El-Essawi","year":"2007","unstructured":"El-Essawi D, Musial JL, Hammad A, Lim HW. A survey of skin disease and skin-related issues in Arab Americans. J Am Acad Dermatol. 2007;56(6):933\u20138 (PubMed PMID: 17321004).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"194_CR19","first-page":"245","volume":"36","author":"M Hiletework","year":"1998","unstructured":"Hiletework M. Skin diseases seen in Kazanchis health center. Ethiop Med J. 1998;36(4):245\u201354 (PubMed PMID: 11957300).","journal-title":"Ethiop Med J"},{"issue":"1","key":"194_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-4362.1988.tb02329.x","volume":"27","author":"M Vazquez","year":"1988","unstructured":"Vazquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men. A clinical and histologic study. Int J Dermatol. 1988;27(1):25\u20137 (PubMed PMID: 3346120).","journal-title":"Int J Dermatol."},{"issue":"7","key":"194_CR21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1468-3083.2009.03524.x","volume":"24","author":"R Sarkar","year":"2010","unstructured":"Sarkar R, Puri P, Jain RK, Singh A, Desai A. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol. 2010;24(7):768\u201372 (PubMed PMID: 20015053).","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"194_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-4632.2009.03778.x","volume":"48","author":"R Pichardo","year":"2009","unstructured":"Pichardo R, Vallejos Q, Feldman SR, Schulz MR, Verma A, Quandt SA, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol. 2009;48(1):22\u20136 (PubMed PMID: 19126046. Pubmed Central PMCID: 2621062).","journal-title":"Int J Dermatol"},{"issue":"1","key":"194_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2008.00579.x","volume":"36","author":"HY Jo","year":"2009","unstructured":"Jo HY, Kim CK, Suh IB, Ryu SW, Ha KS, Kwon YG, et al. Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma. J Dermatol. 2009;36(1):10\u20136 (PubMed PMID: 19207431).","journal-title":"J Dermatol."},{"issue":"3","key":"194_CR24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/15569527.2013.834496","volume":"33","author":"HY Seckin","year":"2014","unstructured":"Seckin HY, Kalkan G, Bas Y, Akbas A, Onder Y, Ozyurt H, et al. Oxidative stress status in patients with melasma. Cutan Ocular Toxicol. 2014;33(3):212\u20137 (PubMed PMID: 24147944).","journal-title":"Cutan Ocular Toxicol."},{"issue":"8","key":"194_CR25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/jid.2010.95","volume":"130","author":"BH Mahmoud","year":"2010","unstructured":"Mahmoud BH, Ruvolo E, Hexsel CL, Liu Y, Owen MR, Kollias N, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092\u20137 (PubMed PMID: 20410914).","journal-title":"J Invest Dermatol."},{"issue":"5","key":"194_CR26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/pcmr.12273","volume":"27","author":"L Duteil","year":"2014","unstructured":"Duteil L, Cardot-Leccia N, Queille-Roussel C, Maubert Y, Harmelin Y, Boukari F, et al. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res. 2014;27(5):822\u20136 (PubMed PMID: 24888214).","journal-title":"Pigment Cell Melanoma Res."},{"issue":"6","key":"194_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2133.2006.07179.x","volume":"154","author":"HY Kang","year":"2006","unstructured":"Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154(6):1094\u20139 (PubMed PMID: 16704639).","journal-title":"Br J Dermatol."},{"issue":"8","key":"194_CR28","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/jid.2011.109","volume":"131","author":"HY Kang","year":"2011","unstructured":"Kang HY, Suzuki I, Lee DJ, Ha J, Reiniche P, Aubert J, et al. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol. 2011;131(8):1692\u2013700 (PubMed PMID: 21562572).","journal-title":"J Invest Dermatol."},{"issue":"1","key":"194_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/jid.2012.270","volume":"133","author":"JY Kim","year":"2013","unstructured":"Kim JY, Lee TR, Lee AY. Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma. J Invest Dermatol. 2013;133(1):191\u2013200 (PubMed PMID: 22951732).","journal-title":"J Invest Dermatol."},{"issue":"8","key":"194_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.0906-6705.2005.00345.x","volume":"14","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. Exp Dermatol. 2005;14(8):625\u201333 (PubMed PMID: 16026585).","journal-title":"Exp Dermatol"},{"issue":"6","key":"194_CR31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1524-4725.2010.01564.x","volume":"36","author":"HI Lee","year":"2010","unstructured":"Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al. Clinicopathologic efficacy of copper bromide plus\/yellow laser (578\u00a0nm with 511\u00a0nm) for treatment of melasma in Asian patients. Dermatol Surg. 2010;36(6):885\u201393 (PubMed PMID: 20482724).","journal-title":"Dermatol Surg"},{"key":"194_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-5945-8-3","volume":"8","author":"H Adalatkhah","year":"2008","unstructured":"Adalatkhah H, Sadeghi-bazargani H, Amini-sani N, Zeynizadeh S. Melasma and its association with different types of nevi in women: a case\u2013control study. BMC Dermatol. 2008;8:3 (Pubmed Central PMCID: 2525625).","journal-title":"BMC Dermatol"},{"issue":"3","key":"194_CR33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjd.13059","volume":"171","author":"AC Handel","year":"2014","unstructured":"Handel AC, Lima PB, Tonolli VM, Miot LD, Miot HA. Risk factors for facial melasma in women: a case\u2013control study. Br J Dermatol. 2014;171(3):588\u201394 (PubMed PMID: 24749693).","journal-title":"Br J Dermatol."},{"issue":"11","key":"194_CR34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1468-3083.2009.03295.x","volume":"23","author":"JP Ortonne","year":"2009","unstructured":"Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23(11):1254\u201362 (PubMed PMID: 19486232).","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"11","key":"194_CR35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1468-3083.2010.03638.x","volume":"24","author":"YH Jang","year":"2010","unstructured":"Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010;24(11):1312\u20136 (PubMed PMID: 20337826).","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"194_CR36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ics.12186","volume":"37","author":"A Tamega Ade","year":"2015","unstructured":"Tamega Ade A, Miot HA, Moco NP, Silva MG, Marques ME, Miot LD. Gene and protein expression of oestrogen-beta and progesterone receptors in facial melasma and adjacent healthy skin in women. Int J Cosmet Sci. 2015;37(2):222\u20138 (PubMed PMID: 25439299).","journal-title":"Int J Cosmet Sci"},{"issue":"1","key":"194_CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jcem-61-1-28","volume":"61","author":"RJ Lutfi","year":"1985","unstructured":"Lutfi RJ, Fridmanis M, Misiunas AL, Pafume O, Gonzalez EA, Villemur JA, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985;61(1):28\u201331 (PubMed PMID: 3923030).","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"194_CR38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","volume":"146","author":"WH Kang","year":"2002","unstructured":"Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228\u201337 (PubMed PMID: 11903232).","journal-title":"Br J Dermatol."},{"key":"194_CR39","doi-asserted-by":"crossref","unstructured":"Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78\u201383, e1\u20132 (PubMed PMID: 20398960).","DOI":"10.1016\/j.jaad.2009.10.051"},{"issue":"9","key":"194_CR40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamadermatol.2016.1006","volume":"152","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues M, Ayala-Cortes AS, Rodriguez-Arambula A, Hynan LS, Pandya AG. Interpretability of the modified melasma area and severity index (mMASI). JAMA Dermatol. 2016;152(9):1051\u20132 (PubMed PMID: 27144383).","journal-title":"JAMA Dermatol."},{"issue":"3","key":"194_CR41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","volume":"149","author":"R Balkrishnan","year":"2003","unstructured":"Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149(3):572\u20137 (PubMed PMID: 14510991).","journal-title":"Br J Dermatol"},{"issue":"3","key":"194_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/DSS.0000000000000642","volume":"42","author":"R Sarkar","year":"2016","unstructured":"Sarkar R, Garg V, Bansal S, Sethi S, Gupta C. Comparative evaluation of efficacy and tolerability of glycolic acid, salicylic mandelic acid, and phytic acid combination peels in melasma. Dermatol Surg. 2016;42(3):384\u201391 (PubMed PMID: 26859648).","journal-title":"Dermatol Surg"},{"issue":"3","key":"194_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jocd.12217","volume":"15","author":"K Mazurek","year":"2016","unstructured":"Mazurek K, Pierzchala E. Comparison of efficacy of products containing azelaic acid in melasma treatment. J Cosmet Dermatol. 2016;15(3):269\u201382 (PubMed PMID: 27028014).","journal-title":"J Cosmet Dermatol."},{"issue":"5","key":"194_CR44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ced.12835","volume":"41","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Park JY, Shibata T, Fujiwara R, Kang HY. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480\u20135 (PubMed PMID: 27135282).","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"194_CR45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jocd.12260","volume":"16","author":"S Dayal","year":"2016","unstructured":"Dayal S, Sahu P, Dua R. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life. J Cosmet Dermatol. 2016;16(1):35\u201342 (PubMed PMID: 27500896).","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"194_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13555-014-0064-z","volume":"4","author":"K Shankar","year":"2014","unstructured":"Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A, et al. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther. 2014;4(2):165\u201386 (Pubmed Central PMCID: 4257945).","journal-title":"Dermatol Ther."},{"key":"194_CR47","doi-asserted-by":"crossref","unstructured":"Boukari F, Jourdan E, Fontas E, Montaudie H, Castela E, Lacour JP, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189\u201390 e1 (PubMed PMID: 25443629).","DOI":"10.1016\/j.jaad.2014.08.023"},{"issue":"1","key":"194_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/phpp.12086","volume":"30","author":"JP Castanedo-Cazares","year":"2014","unstructured":"Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, Fuentes-Ahumada C, Torres-Alvarez B. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35\u201342 (PubMed PMID: 24313385).","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"194_CR49","unstructured":"Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis. 1983;32(1):92, 5\u20136 (PubMed PMID: 6349944)."},{"issue":"6","key":"194_CR50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","volume":"55","author":"AK Gupta","year":"2006","unstructured":"Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048\u201365 (PubMed PMID: 17097400).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"194_CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0019-5154.108070","volume":"58","author":"RC Monteiro","year":"2013","unstructured":"Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58(2):157 (PubMed PMID: 23716817. Pubmed Central PMCID: 3657227).","journal-title":"Indian J Dermatol."},{"issue":"4","key":"194_CR52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0019-5154.113940","volume":"58","author":"KS Deo","year":"2013","unstructured":"Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013;58(4):281\u20135 (PubMed PMID: 23918998. Pubmed Central PMCID: 3726874).","journal-title":"Indian J Dermatol."},{"issue":"4","key":"194_CR53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1993.tb03169.x","volume":"129","author":"CE Griffiths","year":"1993","unstructured":"Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol. 1993;129(4):415\u201321 (PubMed PMID: 8217756).","journal-title":"Br J Dermatol."},{"issue":"6","key":"194_CR54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","volume":"130","author":"CK Kimbrough-Green","year":"1994","unstructured":"Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130(6):727\u201333 (PubMed PMID: 8002642).","journal-title":"Arch Dermatol"},{"key":"194_CR55","doi-asserted-by":"crossref","unstructured":"Huh SY, Shin JW, Na JI, Huh CH, Youn SW, Park KC. The efficacy and safety of 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial. Ann Dermatol. 2010;22(1):21\u20135 (PubMed PMID: 20548876. Pubmed Central PMCID: 2883392).","DOI":"10.5021\/ad.2010.22.1.21"},{"key":"194_CR56","doi-asserted-by":"crossref","unstructured":"Fabbrocini G, De Vita V, Fardella N, Pastore F, Annunziata MC, Mauriello MC, et al. Skin needling to enhance depigmenting serum penetration in the treatment of melasma. Plastic Surg Int. 2011;158241 (PubMed PMID: 22567235. Pubmed Central PMCID: 3335478).","DOI":"10.1155\/2011\/158241"},{"issue":"6","key":"194_CR57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/dth.12332","volume":"29","author":"N Bagherani","year":"2016","unstructured":"Bagherani N, Smoller BR. Efficacy of topical tranexmic acid in the treatment of melasma. Dermatol Ther. 2016;29(6):389\u201390 (PubMed PMID: 26799239).","journal-title":"Dermatol Ther"},{"issue":"3","key":"194_CR58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0974-2077.118403","volume":"6","author":"L Budamakuntla","year":"2013","unstructured":"Budamakuntla L, Loganathan E, Suresh DH, Shanmugam S, Suryanarayan S, Dongare A, et al. A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg. 2013;6(3):139\u201343 (PubMed PMID: 24163529. Pubmed Central PMCID: 3800287).","journal-title":"J Cutan Aesthet Surg"},{"issue":"3","key":"194_CR59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/14764172.2012.685478","volume":"14","author":"P Kanechorn Na Ayuthaya","year":"2012","unstructured":"Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150\u20134 (PubMed PMID: 22506692).","journal-title":"J Cosmet Laser Ther"},{"issue":"2","key":"194_CR60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385\u201392 (PubMed PMID: 27206758).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"194_CR61","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00266-012-9899-9","volume":"36","author":"S Wu","year":"2012","unstructured":"Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964\u201370 (PubMed PMID: 22552446).","journal-title":"Aesthetic Plast Surg"},{"issue":"5","key":"194_CR62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/dth.12313","volume":"29","author":"N Bagherani","year":"2016","unstructured":"Bagherani N. Efficacy of topical flutamide in the treatment of melasma. Dermatol Ther. 2016;29(5):297 (PubMed PMID: 27712039).","journal-title":"Dermatol Ther"},{"issue":"9 Suppl","key":"194_CR63","first-page":"s123","volume":"12","author":"AF Alexis","year":"2013","unstructured":"Alexis AF, Blackcloud P. Natural ingredients for darker skin types: growing options for hyperpigmentation. J Drugs Dermatol JDD. 2013;12(9 Suppl):s123\u20137 (PubMed PMID: 24002160).","journal-title":"J Drugs Dermatol JDD."},{"issue":"4","key":"194_CR64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","volume":"25","author":"JT Lim","year":"1999","unstructured":"Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermat Surg. 1999;25(4):282\u20134 (PubMed PMID: 10417583).","journal-title":"Dermat Surg"},{"issue":"1","key":"194_CR65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(96)90830-0","volume":"34","author":"K Kameyama","year":"1996","unstructured":"Kameyama K, Sakai C, Kondoh S, Yonemoto K, Nishiyama S, Tagawa M, et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol. 1996;34(1):29\u201333 (PubMed PMID: 8543691).","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"194_CR66","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","volume":"43","author":"LE Espinal-Perez","year":"2004","unstructured":"Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43(8):604\u20137 (PubMed PMID: 15304189).","journal-title":"Int J Dermatol"},{"issue":"5","key":"194_CR67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1590\/S0365-05962010000500003","volume":"85","author":"A Costa","year":"2010","unstructured":"Costa A, Moises TA, Cordero T, Alves CR, Marmirori J. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol. 2010;85(5):613\u201320 (PubMed PMID: 21152784).","journal-title":"An Bras Dermatol."},{"issue":"2","key":"194_CR68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2009.09477.x","volume":"162","author":"AB Kimball","year":"2010","unstructured":"Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162(2):435\u201341 (PubMed PMID: 19845667).","journal-title":"Br J Dermatol."},{"issue":"2","key":"194_CR69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3892\/etm.2014.2118","volume":"9","author":"SM Zhong","year":"2015","unstructured":"Zhong SM, Sun N, Liu HX, Niu YQ, Wu Y. Reduction of facial pigmentation of melasma by topical lignin peroxidase: a novel fast-acting skin-lightening agent. Exp Ther Med. 2015;9(2):341\u20134 (PubMed PMID: 25574195. Pubmed Central PMCID: 4280934).","journal-title":"Exp Ther Med"},{"issue":"3","key":"194_CR70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jocd.12147","volume":"14","author":"M Morag","year":"2015","unstructured":"Morag M, Nawrot J, Siatkowski I, Adamski Z, Fedorowicz T, Dawid-Pac R, et al. A double-blind, placebo-controlled randomized trial of Serratula quinquefolia folium, a new source of beta-arbutin, in selected skin hyperpigmentations. J Cosmet Dermatol. 2015;14(3):185\u201390 (PubMed PMID: 26119285).","journal-title":"J Cosmet Dermatol."},{"issue":"9","key":"194_CR71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1346-8138.1998.tb02463.x","volume":"25","author":"WH Kang","year":"1998","unstructured":"Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol. 1998;25(9):587\u201396 (PubMed PMID: 9798345).","journal-title":"J Dermatol."},{"issue":"3","key":"194_CR72","first-page":"697","volume":"159","author":"R Chan","year":"2008","unstructured":"Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697\u2013703 (PubMed PMID: 18616780).","journal-title":"Br J Dermatol."},{"key":"194_CR73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-1-4615-4857-7_72","volume":"455","author":"YC Kauh","year":"1999","unstructured":"Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol. 1999;455:491\u20139 (PubMed PMID: 10599387).","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"194_CR74","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1365-2133.2002.04900.x","volume":"147","author":"SA Holme","year":"2002","unstructured":"Holme SA, Beattie PE, Fleming CJ. Cosmetic camouflage advice improves quality of life. Br J Dermatol. 2002;147(5):946\u20139 (PubMed PMID: 12410705).","journal-title":"Br J Dermatol."},{"issue":"8","key":"194_CR75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamadermatol.2013.4294","volume":"149","author":"AM Ahmed","year":"2013","unstructured":"Ahmed AM, Lopez I, Perese F, Vasquez R, Hynan LS, Chong B, et al. A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. JAMA Dermatol. 2013;149(8):981\u20133 (PubMed PMID: 23740292).","journal-title":"JAMA Dermatol."},{"issue":"2","key":"194_CR76","first-page":"148","volume":"13","author":"SZ Choudhry","year":"2014","unstructured":"Choudhry SZ, Bhatia N, Ceilley R, Hougeir F, Lieberman R, Hamzavi I, et al. Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature. J Drugs Dermatol. 2014;13(2):148\u201353 (PubMed PMID: 24509964).","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"194_CR77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09546631003801619","volume":"23","author":"N Arjinpathana","year":"2012","unstructured":"Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatol Treatm. 2012;23(2):97\u2013102 (PubMed PMID: 20524875).","journal-title":"J Dermatol Treatm"},{"issue":"8","key":"194_CR78","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1524-4725.2011.02018.x","volume":"37","author":"WS Jang","year":"2011","unstructured":"Jang WS, Lee CK, Kim BJ, Kim MN. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients. Dermatol Surg. 2011;37(8):1133\u201340 (PubMed PMID: 21585597).","journal-title":"Dermatol Surg"},{"issue":"8","key":"194_CR79","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1524-4725.2010.01621.x","volume":"36","author":"TM Katz","year":"2010","unstructured":"Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Dermatol Surg. 2010;36(8):1273\u201380 (PubMed PMID: 20666816).","journal-title":"Dermatol Surg"},{"issue":"2","key":"194_CR80","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/lsm.20603","volume":"40","author":"JM Park","year":"2008","unstructured":"Park JM, Tsao H, Tsao S. Combined use of intense pulsed light and Q-switched ruby laser for complex dyspigmentation among Asian patients. Lasers Surg Med. 2008;40(2):128\u201333 (PubMed PMID: 18306166).","journal-title":"Lasers Surg Med"},{"issue":"12","key":"194_CR81","first-page":"1645","volume":"31","author":"CK Rokhsar","year":"2005","unstructured":"Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;31(12):1645\u201350 (PubMed PMID: 16336881).","journal-title":"Dermatol Surg"},{"issue":"3","key":"194_CR82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1524-4725.2009.01066.x","volume":"35","author":"R Wanitphakdeedecha","year":"2009","unstructured":"Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, Chen TM. Treatment of melasma using variable square pulse Er:YAG laser resurfacing. Dermatol Surg. 2009;35(3):475\u201381 (discussion 81\u20132. PubMed PMID: 19250309).","journal-title":"Dermatol Surg"},{"issue":"5","key":"194_CR83","first-page":"372","volume":"82","author":"M Rendon","year":"2008","unstructured":"Rendon M, Cardona LM, Bussear EW, Benitez AL, Colon LE, Johnson LA. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study. Cutis. 2008;82(5):372\u20138 (PubMed PMID: 19090343).","journal-title":"Cutis"},{"issue":"5","key":"194_CR84","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-4362.2001.01149.x","volume":"40","author":"SM Javaheri","year":"2001","unstructured":"Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001;40(5):354\u20137 (PubMed PMID: 11555002).","journal-title":"Int J Dermatol"},{"issue":"12","key":"194_CR85","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archderm.138.12.1578","volume":"138","author":"ME Hurley","year":"2002","unstructured":"Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol. 2002;138(12):1578\u201382 (PubMed PMID: 12472345).","journal-title":"Arch Dermatol"},{"issue":"6","key":"194_CR86","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaad.2009.12.027","volume":"63","author":"S Kodali","year":"2010","unstructured":"Kodali S, Guevara IL, Carrigan CR, Daulat S, Blanco G, Boker A, et al. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. J Am Acad Dermatol. 2010;63(6):1030\u20135 (PubMed PMID: 20889235).","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"194_CR87","first-page":"447","volume":"76","author":"R Kumari","year":"2010","unstructured":"Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76(4):447 (PubMed PMID: 20657143).","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"194_CR88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DSS.0000000000000924","volume":"43","author":"A Hou","year":"2017","unstructured":"Hou A, Cohen B, Haimovic A, Elbuluk N. Microneedling: a comprehensive review. Dermatol Surg. 2017;43(3):321\u201339 (PubMed PMID: 27755171).","journal-title":"Dermatol Surg"},{"issue":"2","key":"194_CR89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2015.09.024","volume":"74","author":"BE Cohen","year":"2016","unstructured":"Cohen BE, Elbuluk N. Microneedling in skin of color: a review of uses and efficacy. J Am Acad Dermatol. 2016;74(2):348\u201355 (PubMed PMID: 26549251).","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"194_CR90","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","volume":"20","author":"CR Taylor","year":"1994","unstructured":"Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592\u20137 (PubMed PMID: 8089359).","journal-title":"J Dermatol Surg Oncol."},{"issue":"4","key":"194_CR91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jocd.12253","volume":"15","author":"H Gokalp","year":"2016","unstructured":"Gokalp H, Akkaya AD, Oram Y. Long-term results in low-fluence 1064-nm Q-Switched Nd:yAG laser for melasma: is it effective? J Cosmet Dermatol. 2016;15(4):420\u20136 (PubMed PMID: 27349828).","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"194_CR92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/DSS.0000000000000653","volume":"42","author":"CA Hofbauer Parra","year":"2016","unstructured":"Hofbauer Parra CA, Careta MF, Valente NY, de Sanches Osorio NE, Torezan LA. Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2016;42(4):507\u201312 (PubMed PMID: 26963146).","journal-title":"Dermatol Surg"},{"issue":"2","key":"194_CR93","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sder.2012.02.002","volume":"31","author":"AN Kauvar","year":"2012","unstructured":"Kauvar AN. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers. Semin Cutan Med Surg. 2012;31(2):126\u201332 (PubMed PMID: 22640433).","journal-title":"Semin Cutan Med Surg"},{"issue":"8","key":"194_CR94","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s10103-016-2034-4","volume":"31","author":"B Yue","year":"2016","unstructured":"Yue B, Yang Q, Xu J, Lu Z. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Lasers Med Sci. 2016;31(8):1657\u201363 (PubMed PMID: 27450275).","journal-title":"Lasers Med Sci"},{"issue":"5","key":"194_CR95","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/14764172.2015.1027227","volume":"17","author":"WJ Yun","year":"2015","unstructured":"Yun WJ, Lee SM, Han JS, Lee SH, Chang SY, Haw S, et al. A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians. J Cosmet Laser Ther. 2015;17(5):259\u201366 (PubMed PMID: 25803571).","journal-title":"J Cosmet Laser Ther"},{"key":"194_CR96","first-page":"1","volume":"3","author":"LG Tong","year":"2016","unstructured":"Tong LG, Wu Y, Wang B, Xu XG, Tu HD, Chen HD, et al. Combination of fractional QSRL and IPL for melasma treatment in chinese population. J Cosmet Laser Ther. 2016;3:1\u201319 (PubMed PMID: 27594596).","journal-title":"J Cosmet Laser Ther"},{"issue":"1","key":"194_CR97","first-page":"59","volume":"29","author":"S Angsuwarangsee","year":"2003","unstructured":"Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg. 2003;29(1):59\u201364 (PubMed PMID: 12534514).","journal-title":"Dermatol Surg"},{"issue":"6","key":"194_CR98","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1524-4725.1999.08248.x","volume":"25","author":"K Nouri","year":"1999","unstructured":"Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999;25(6):494\u20137 (PubMed PMID: 10469101).","journal-title":"Dermatol Surg"},{"issue":"4","key":"194_CR99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40257-014-0080-x","volume":"15","author":"NY Jalaly","year":"2014","unstructured":"Jalaly NY, Valizadeh N, Barikbin B, Yousefi M. Low-power fractional CO(2) laser versus low-fluence Q-switch 1,064\u00a0nm Nd:yAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014;15(4):357\u201363 (PubMed PMID: 24858737).","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"194_CR100","first-page":"748","volume":"40","author":"N Cameli","year":"2014","unstructured":"Cameli N, Abril E, Mariano M, Berardesca E. Combined use of monopolar radiofrequency and transdermal drug delivery in the treatment of melasma. Dermatol Surgery. 2014;40(7):748\u201355 (PubMed PMID: 25111347).","journal-title":"Dermatol Surgery"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-017-0194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T15:51:55Z","timestamp":1750780315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-017-0194-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s13555-017-0194-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}